NEO:NASDAQ
NeoGenomics, Inc.
16,56 USD
arrow_downward
-1,57%(-0,26) 1D
12-ноя., 13:07:22 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NEO...
Open
16,45 USD
High
16,69 USD
Low
16,11 USD
Mkt. cap
2,14 млд
Avg. vol.
2,01 млн
Volume
297,32 миң
52-wk high
20,15 USD
52-wk low
7,06 USD
EPS
-0,25 USD
Beta
1,87
Shares outstanding
129,39 млн
No. of employees
2 миң
Open
16,45 USD
High
16,69 USD
Low
16,11 USD
Mkt. cap
2,14 млд
Avg. vol.
2,01 млн
Volume
297,32 миң
52-wk high
20,15 USD
52-wk low
7,06 USD
EPS
-0,25 USD
Beta
1,87
Shares outstanding
129,39 млн
No. of employees
2 миң
News stories
From web sources and news partners
GuruFocus
·
1 күн мурун
NeoGenomics Inc (NEO) Shares Fall 3.6% -- What GF Score of 74 Tells Investors
Profile
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas. Wikipedia
About NeoGenomics, Inc.
CEOChristopher M. Smith
Employees2,5 миң
Founded2002
HeadquartersФорт Майерс, Флорида, Америка Кошмо Штаттары
SectorHealth Care
IndustryHealth care provider
Websiteneogenomics.com